Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Regression of B-Cell Lymphoma of the Liver with Hepatitis C Virus Infection After Treatment with Pegylated Interferon-α and Ribavirin

By Oda Yayoi   Kou Tadayuki   Watanabe Masaki   Sakuma Yojiro   Taguchi Nori   Kato Yoko   Kudo Yasushi   Yamauchi Atsushi   Sugiura Yasushi   Ohashi Shinya   Asada Masanori   Fukunaga Toyokazu   Kawaguchi Kiyotaka   Ito Hiroaki   Nakamura Takefumi   Yazumi Shujiro  

Digestive Diseases and Sciences, Vol. 55, Iss. 6, 2010-06 ,pp. : 1791-1793

Springer Publishing Company

Access to resources Recommend Favorite

Antiviral Treatment of Patients with Recurrent Hepatitis C After Liver Transplantation with Pegylated Interferon

By Schmidt Sven   Bahra Marcus   Bayraktar Sandra   Berg Thomas   Schmeding Maximilian   Pratschke Johann   Neuhaus Peter   Neumann Ulf  

Digestive Diseases and Sciences, Vol. 55, Iss. 7, 2010-07 ,pp. : 2063-2069

Springer Publishing Company

Access to resources Recommend Favorite

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load

By  

Case Reports in Gastroenterology, Vol. 3, Iss. 3, 2009-11 ,pp. : 372-376

Karger

Access to resources Recommend Favorite

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

By Syed Eliya   Rahbin Nogol   Weiland Ola   Carlsson Tony   Oksanen Antti   Birk Markus   Davidsdottir Loa   Hagen Karin   Hultcrantz Rolf   Aleman Soo  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1378-1386

Informa Healthcare

Access to resources Recommend Favorite